C4BPA and pachyonychia congenita: Serum concentrations of complement component 4 binding protein alpha (C4BPA) were reported to be altered in patients with PC and other gastroenterological cancers and to allow the detection of early-stage PC and differentiation between PC and other gastrointestinal cancers [39].